On August 28, 2019, the DOJ reported that 41 individuals had been charged in 9 indictments for their alleged involvement in a network of “pill mill” clinics and pharmacies. Among those charged were medical providers, clinic owners and managers, pharmacists, pharmacy owners and managers, drug dealers, and traffickers. Their actions allegedly resulted in the diversion of approximately 23 million oxycodone, hydrocodone, and carisoprodol pills. Additionally, federal agents executed 36 search warrants at 15 pharmacies and six “pill mill” clinics, as well as other offices and residences. The DEA served immediate suspension orders on seven pharmacies and two providers allegedly involved in the unlawful dispensing of controlled substances. The charges alleged participants knew that the prescriptions had no legitimate medical purpose and were issued outside the usual course of professional practice.